Characteristics of Disseminated Her2+ Breast Cancer Patients Treated With Trastuzumab That Have Reached Complete, Partial Remission or Stabilization of Disease During More Than 3 Years
Clinical trial NCT01433926 · COMPLETED
Trial details
- NCT number
- NCT01433926
- Sponsor
- Asociación para el Progreso de la Oncología en Málaga
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-03-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.